The Neuroprotective Effects of Moderate and Regular Caffeine Consumption in Alzheimer’s Disease

Authors:
Open Access
Publisher website
Google Scholar
Abstract
The increasing numbers of elderly Alzheimer’s disease (AD) patients because of a steady increase in the average lifespan and aging society attract great scientific concerns, while there were fewer effective treatments on AD progression due to unclear exact causes and pathogenesis of AD. Moderate (200‐500 mg/d) and regular caffeine consumption from coffee and tea are considered to alleviate the risk of AD and have therapeutic potential. This paper reviewed epidemiological studies about the relationship of caffeine intake from coffee or/and tea with the risk of AD and summarized the caffeine‐related AD therapies based on experimental models. And further well‐designed and well‐conducted studies are suggested to investigate the optimal dosages, frequencies, and durations of caffeine consumption to slow down AD progression and treat AD.
Funding Information
  • Hunan Key Laboratory for Processing of Special Medicine Food (2017TP1021, 2020NK2020)
  • Hunan Key Research and Development Plan Project (2017TP1021, 2020NK2020)

This publication has 86 references indexed in Scilit: